[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

Clinical trial NCT06125028 · TERMINATED

Trial details

NCT number: NCT06125028
Sponsor: Pentixapharm AG
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Marginal Zone Lymphoma

Start date: 2024-05-20
Primary completion: 2025-07-18
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.